第六章:成人结核病预防治疗

G. Alvarez, C. Pease, D. Menzies
{"title":"第六章:成人结核病预防治疗","authors":"G. Alvarez, C. Pease, D. Menzies","doi":"10.1080/24745332.2022.2039498","DOIUrl":null,"url":null,"abstract":"• Either once-weekly rifapentine and isoniazid for 3 months (3HP), or daily rifampin for 4 months (4R) is recommended. • When rifamycin based regimens cannot be used because they are not tolerated, not feasible or are contraindicated, the 9-month daily isoniazid regimen (9H) is the preferred option. • When the 9H regimen cannot be used, the six-month daily isoniazid regimen (6H) is recommended. • Evaluate for interactions between patients’ baseline medications and the prospective TPT regimen through an up-to-date drug decision support tool prior to treatment initiation.","PeriodicalId":9471,"journal":{"name":"Canadian Journal of Respiratory, Critical Care, and Sleep Medicine","volume":"53 1","pages":"77 - 86"},"PeriodicalIF":1.5000,"publicationDate":"2022-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"5","resultStr":"{\"title\":\"Chapter 6: Tuberculosis preventive treatment in adults\",\"authors\":\"G. Alvarez, C. Pease, D. Menzies\",\"doi\":\"10.1080/24745332.2022.2039498\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"• Either once-weekly rifapentine and isoniazid for 3 months (3HP), or daily rifampin for 4 months (4R) is recommended. • When rifamycin based regimens cannot be used because they are not tolerated, not feasible or are contraindicated, the 9-month daily isoniazid regimen (9H) is the preferred option. • When the 9H regimen cannot be used, the six-month daily isoniazid regimen (6H) is recommended. • Evaluate for interactions between patients’ baseline medications and the prospective TPT regimen through an up-to-date drug decision support tool prior to treatment initiation.\",\"PeriodicalId\":9471,\"journal\":{\"name\":\"Canadian Journal of Respiratory, Critical Care, and Sleep Medicine\",\"volume\":\"53 1\",\"pages\":\"77 - 86\"},\"PeriodicalIF\":1.5000,\"publicationDate\":\"2022-03-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"5\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Canadian Journal of Respiratory, Critical Care, and Sleep Medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1080/24745332.2022.2039498\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"RESPIRATORY SYSTEM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Canadian Journal of Respiratory, Critical Care, and Sleep Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/24745332.2022.2039498","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 5

摘要

•推荐每周使用一次利福喷丁和异烟肼,持续3个月(3HP),或每天使用利福平,持续4个月(4R)。•当利福霉素为基础的方案不能使用,因为他们不能耐受,不可行或禁忌,9个月每日异烟肼方案(9H)是首选。•当不能使用9H方案时,建议使用6个月每日异烟肼方案(6H)。•在治疗开始前,通过最新的药物决策支持工具评估患者基线药物与预期TPT方案之间的相互作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Chapter 6: Tuberculosis preventive treatment in adults
• Either once-weekly rifapentine and isoniazid for 3 months (3HP), or daily rifampin for 4 months (4R) is recommended. • When rifamycin based regimens cannot be used because they are not tolerated, not feasible or are contraindicated, the 9-month daily isoniazid regimen (9H) is the preferred option. • When the 9H regimen cannot be used, the six-month daily isoniazid regimen (6H) is recommended. • Evaluate for interactions between patients’ baseline medications and the prospective TPT regimen through an up-to-date drug decision support tool prior to treatment initiation.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
1.90
自引率
12.50%
发文量
51
期刊最新文献
Cost-effectiveness of triple therapy with budesonide/glycopyrronium/formoterol fumarate dihydrate compared with dual therapy for the treatment of chronic obstructive pulmonary disease (COPD) in Canada Lymphoplasmacytic lymphoma and HIV: A case report Effect of geographical distance on repeat pleural procedures in patients managed by indwelling pleural catheters: A retrospective cohort study Medical industry contributions to the climate crisis: Behind the green drapes Chapitre 4: Le diagnostic de l’infection tuberculeuse
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1